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Abstract. 
 
Expression of the type II collagen gene (hu-
 
man 
 
COL2A1
 
, mouse 
 
Col2a1
 
) heralds the differentia-
tion of chondrocytes. It is also expressed in progenitor 
cells of some nonchondrogenic tissues during embryo-
 
genesis. DNA sequences in the 5
 
9 
 
flanking region and 
intron 1 are known to control tissue-specific expression 
in vitro, but the regulation of 
 
COL2A1
 
 expression in 
vivo is not clearly understood. We have tested the regu-
latory activity of DNA sequences from 
 
COL2A1
 
 on the 
expression of a 
 
lacZ
 
 reporter gene in transgenic mice. 
We have found that type II collagen characteristic ex-
pression of the transgene requires the enhancer activity 
of a 309-bp fragment (
 
1
 
2,388 to 
 
1
 
2,696) in intron 1 in 
conjunction with 6.1-kb 5
 
9
 
 sequences. Different regula-
tory elements were found in the 1.6-kb region (
 
1
 
701 to 
 
1
 
2,387) of intron 1 which only needs 90-bp 5
 
9
 
 se-
quences for tissue-specific expression in different com-
ponents of the developing cartilaginous skeleton. Dis-
tinct positive and negative regulatory elements act 
together to control tissue-specific transgene expression 
in the developing midbrain neuroepithelium. Positive 
elements affecting expression in the midbrain were 
found in the region from 
 
2
 
90 to 
 
2
 
1,500 and from 
 
1
 
701 
to 
 
1
 
2,387, whereas negatively acting elements were de-
tected in the regions from 
 
2
 
1,500 to 
 
2
 
6,100 and 
 
1
 
2,388 
to 
 
1
 
2,855.
 
D
 
uring
 
 embryogenesis, the selective and combinato-
rial expression of genes signifies the developmen-
tal program and phenotype of differentiated cells.
The activation and repression of gene expression is usually
controlled at the level of transcription by multiple positive
and negative regulatory elements (Darnell, 1982; Gutman
et al., 1994).
Expression of the type II collagen gene is a hallmark of
chondrogenesis in vertebrates. In chickens, rodents, and
humans, the type II collagen gene is transcribed at high
levels by cells of the chondrogenic lineage (Kosher et al.,
1986; Cheah et al., 1991; Ng et al., 1993; Lui et al., 1995). In
 
Xenopus
 
, avian, and mouse embryos (Von der Mark et
al., 1976; Kravis and Upholt, 1985; Kosher et al., 1986;
Thorogood et al., 1986; Swalla et al., 1988; Kosher and
Solursh, 1989; Cheah et al., 1991; Su et al., 1991; Wood et al.,
1991; Ng et al., 1993), expression of the type II collagen
gene is not restricted to chondrogenic cells. In humans,
 
COL2A1
 
 mRNAs are also widely expressed in tissues that
are not involved in cartilage formation, such as the noto-
chord, neural retina, heart, fetal brain, and the epithelium of
the otic vesicle (Sandell, 1994; Lui et al., 1995; see Table I 
 
a
 
).
The complex expression pattern of type II collagen in
chondrogenic and nonchondrogenic tissues during verte-
brate development implies intricate regulation. Several
 
cis
 
-regulatory elements important for chondrogenic ex-
pression of the type II collagen gene have been identified
for the rat and mouse genes by assaying the activity of
transfected reporter genes in cultured chondrocytes. Such
studies identified sequences in the first intron of the rat
and mouse type II collagen genes that bind chondrocyte-
specific proteins (Horton et al., 1987; Wang et al., 1991;
Lefebvre et al., 1996) and are important for enhancer ac-
tivity (Horton et al., 1987; Wang et al., 1991; Mukho-
padhyay et al., 1995; Krebsbach et al., 1996; Lefebvre et al.,
 
1996). The 5
 
9
 
 flanking region of the type II collagen gene
contains domains that repress transcription in cultured
nonchondrocytic cells in vitro (Savagner et al., 1990). Syn-
ergistic action between the rat type II collagen gene pro-
moter and first intron has also been shown (Savagner et
al., 1995). In the human 
 
COL2A1
 
, a helix-loop-helix rec-
ognition sequence, analogous to the intron 1 decamer en-
hancer sequence of the rat gene, has been found to be
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critical for maintaining basal activity of the promoter (Seg-
hatoleslami et al., 1994).
The importance of sequence elements for tissue-specific
expression of genes is often inferred from cotransfection
assays in cultured cells. Although such studies are valu-
able, differing results may be obtained depending on
whether transfection is stable or transient. It is also not
possible to identify elements important for stage specific-
ity of expression by this approach. Experiments using
transgenic animals to recapitulate the normal pattern of
gene expression have shown that in certain cases, such as
elastase and 
 
a
 
1(I) collagen genes that DNA sequences
identified as essential for gene regulation in transfected
cells may not have any functional role in vivo (Swift et al.,
1989; Sokolov et al., 1995).
The regulatory activity of some type II collagen gene se-
quences has been examined in vivo by transgenesis. The
first intron of the mouse type II collagen gene (
 
Col2a1
 
) is
essential for cartilage-specific expression of an 
 
Escherichia
coli
 
 
 
b
 
-galactosidase (
 
lacZ
 
) reporter gene in transgenic
mice (Metsäranta et al., 1995). Sequences within a 182-bp
fragment of the mouse 
 
Col2a1
 
 first intron were also shown
to direct chondrogenic expression of a 
 
lacZ
 
 reporter gene
when present as tandem copies (Mukhopadhyay et al.,
1995; Zhou et al., 1995). However, some sequences shown
to be important for enhancer activity of the first intron in
cell transfection assays were found to be redundant for
chondrocyte-specific expression (Mukhopadhyay et al.,
1995). These studies on the regulation of the 
 
Col2a1
 
 gene
have concentrated mainly on defining minimal sequences
important for chondrocyte-specific enhancer activity and
on expression in the chondrogenic lineage from 10.5 days
post coitum (dpc)
 
1
 
 in the mouse. The elements necessary
for expression of
 
 Col2a1
 
 before 10.5 dpc and in nonchon-
drogenic tissues in the mouse have not been determined.
Furthermore, the transgenic studies performed so far have
not revealed any activity of the silencing (repressor) ele-
ments that have been identified by cell transfection studies
(Savagner et al., 1990; Seghatoleslami et al., 1994).
The sequence elements directing human type II collagen
gene expression are not well defined. We have previously
shown that a 30-kbp genomic fragment containing the hu-
man 
 
COL2A1 
 
gene can be expressed in chondrogenic tis-
sues in the mouse (Lovell Badge et al., 1987). More recent
studies on the 
 
COL2A1
 
 gene have shown that a combina-
tion of 1.8-kbp 5
 
9
 
 flanking DNA with a 3.0-kbp first intron
or 4.5-kbp upstream sequence with 1.8-kbp of intron 1
DNA, was sufficient for chondrogenic-specific 
 
lacZ
 
 re-
porter gene expression in transgenic mice (Seghatoleslami
et al., 1994; Cheah et al., 1995). These studies concentrated
on later stages and on the chondrogenic lineage; there is
little information on the 
 
cis
 
-regulatory elements governing
 
COL2A1
 
 transcription in vivo or the ability of these se-
quences to direct expression at early stages of embryogen-
esis and in nonchondrogenic tissues. We have assayed such
elements in the 5
 
9
 
 flanking and intron 1 regions of
 
COL2A1
 
 expressed in transgenic mice.
 
A prerequisite for analysis of the regulation of the hu-
man COL2A1 gene in mice is that the developmental pat-
tern of expression can be recapitulated in the transgenic
animal. We have previously shown very similar patterns of
expression of the endogenous human and mouse type II
collagen genes in nonchondrogenic and prechondrogenic
cells from stages equivalent to 9.5 dpc in mouse embryos
(Ng et al., 1993; Lui et al., 1995). To provide a starting
point for the identification of regulatory elements control-
ling appropriate 
 
COL2A1
 
 transcription in this study, we
compared expression of a genomic clone containing 
 
COL2A1
 
in transgenic mice with that of the endogenous mouse
 
Col2a1 
 
gene. In addition, we have studied the regulation
of 
 
COL2A1
 
 expression in transgenic mice during early or-
ganogenesis and fetal stages.
In the present study we identified a 309-bp fragment
within the first intron of human 
 
COL2A1
 
 which is capable
of directing reporter transgene (
 
COL2A1
 
-
 
lacZ
 
) expres-
sion in prechondrogenic and chondrogenic sites as well as
in a subset of nonchondrogenic tissues (such as node, neu-
ral crest cells, and notochord), characteristic of type II col-
lagen. These sequences were sufficient for correct tempo-
ral regulation of gene expression. We show that the 5
 
9
 
flanking DNA and the first intron need to work synergisti-
cally to direct the expression of the transgene in tissues
that normally express 
 
Col2a1
 
. We present evidence that
positive and negative tissue-specific regulatory elements in
the first intron and the 5
 
9
 
 flanking region of the 
 
COL2A1
 
gene are important for directing expression in the devel-
oping midbrain neuroepithelium.
 
Materials and Methods
 
Transgenes
 
Cosmid clone cosHcol2 contained the complete human 
 
COL2A1
 
 struc-
tural gene with a 9.1-kbp 5
 
9
 
 flanking and a 1.7-kbp 3
 
9
 
 flanking DNA (gift
of E. Solomon, Imperial Cancer Research Fund, London, UK).
Reporter gene constructs were created in pPOLYIII I vector by fusing
various lengths of 5
 
9
 
-flanking promoter sequences to a 125-bp 5
 
9
 
 untrans-
lated region of human 
 
COL2A1
 
 gene and an 
 
E
 
.
 
 coli 
 
b
 
-galactosidase
(
 
lacZ
 
) reporter gene cassette with an initiation translation codon and
polyadenylation signal, followed by various lengths of the first intron of
the human 
 
COL2A1
 
 gene. The 
 
COL2A1
 
 content in the different con-
structs were as shown in Fig. 1. For ease of reference, the intron 1 se-
quences analyzed in this study have been subdivided into three regions,
designated X, Y and Z, the coordinates of which are 
 
1
 
701 to 
 
1
 
2,387,
 
1
 
2,388 to 
 
1
 
2,696, and 
 
1
 
2,697 to 
 
1
 
2,855, respectively (see Figs. 1 and 6).
 
Production of Transgenic Mice
 
Transgenic mice harboring the various 
 
COL2A1
 
 constructs were gener-
ated by pronuclear injection of one-cell zygotes of F1 (CBA 
 
3 
 
C57BL6)
hybrid mice as described (Hogan et al., 1986). Transgenic fetuses were
collected at different stages of development and tested for integration of
the transgene by PCR. PCR was performed on genomic DNA using oligo-
nucleotide primers for the 
 
lacZ
 
 gene 5
 
9
 
-CGTAATAGCGAAGAGGC-
CCG-3
 
9 
 
(nucleotides [nt] 112–130; translation start 
 
5 
 
1); and 5
 
9
 
-TCC-
AACGCAGCACCATCACC-3
 
9
 
 (complementary to nt 558–577). PCR
reactions, containing 2.5 U 
 
Taq
 
 polymerase (Life Technologies, Inc.,
Gaithersburg, MD), were denatured at 95
 
8
 
C for 3 min, followed by 30 cy-
cles of 95
 
8
 
C for 1 min, denaturing, 55
 
8
 
C for 1 min, annealing, and then
72
 
8
 
C for 1 min of elongation.
 
Section and Whole Mount In Situ Hybridization
 
In situ hybridization to sections was carried out as described previously
(Cheah et al., 1991; Nonchev et al., 1996). Two hybridization probes used
 
1.
 
Abbreviations used in this paper
 
: dpc, day(s) post coitum; nt, nucle-
otide(s). 
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were human 
 
COL2A1
 
-specific (KH14) and mouse 
 
Col2a1
 
-specific (KH15).
KH14 and KH15 probes each contained 70 bp of relatively less conserved
3
 
9
 
 untranslated sequence from equivalent regions of the human and mouse
type II collagen genes corresponding to 
 
1
 
31,102 to 
 
1
 
31,171 (
 
COL2A1
 
) and
 
1
 
28,624 to 
 
1
 
28,693 (
 
Col2a1
 
), i.e., KH14 is the human homologue of
KH15. These probes were so designed because they contained short
stretches of nonconserved bases and were species-specific when sections
were treated with RNase posthybridization, and then washed at high strin-
gency. Autoradiography and photography of sections were carried out as
described previously (Cheah et al., 1991).
Whole mount in situ
 
 
 
hybridization on 8.0–9.0 dpc CBA mouse embryos
was carried out as described by Wilkinson (1992) using single-stranded,
digoxgenin-UTP (Boehringer Mannheim, Mannheim, Germany)–labeled
antisense riboprobes generated from pNJ61 (Ng et al., 1993), which con-
tains exon 1–5B of 
 
Col2a1
 
.
 
X-Gal Staining and Histochemistry
 
Mouse embryos or fetuses of various stages were harvested in PBS, pH
7.4, and then fixed for 15–60 min, according to their size, at 4
 
8
 
C in 4%
paraformaldehyde in PBS. They were assayed for expression of 
 
lacZ
 
 by
X-gal (5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
d
 
-galactopyranoside) staining essen-
tially as described in Yee and Rigby (1993). After staining, fetuses were
embedded in paraffin. 6-
 
m
 
m sections were counterstained with eosin.
 
Results
 
Human COL2A1 Transgene Is Expressed Like the 
Endogenous Col2a1 Gene
 
The expression of 45.8-kbp transgene, cosHcol2, contain-
ing the whole 
 
COL2A1
 
 gene, 9.1-kbp 5
 
9
 
 and 1.7-kbp 39
flanking sequence was examined by in situ hybridization
using riboprobes specific for the human transgene (KH14)
and the mouse gene (KH15). The COL2A1 transgene and
the mouse Col2a1 gene were coexpressed in the prechon-
drogenic mesenchyme and chondrocytes (Fig. 2, a, c, and e;
Table I b, COL2A1; Fig. 2, b, d, and f; Table I c, Col2a1).
COL2A1 was also expressed in the nonchondrogenic tis-
sues that express the Col2a1 gene, such as the brain (Fig. 2
a) and otic vesicle (Fig. 2 c). However, COL2A1 transgene
was not expressed in the mouse heart (Fig. 2 c) which nor-
mally expresses the Col2a1 gene strongly. No ectopic ex-
pression of the transgene was found. COL2A1 riboprobe
did not display any nonspecific hybridization in nontrans-
genic mouse embryo (Fig. 2 g).
Identifying the cis-Acting Elements for
COL2A1-specific Expression
To test the activity of the cis-acting elements that may di-
rect lineage-specific expression of the COL2A1 gene, a
COL2A1-lacZ transgene (Fig. 1, pKL9), containing the
6.1-kbp (21 to 26,100) 59 flanking sequence, 125-bp 59 un-
translated region and 2.1-kbp intron 1 (1701 to 12,855,
regions X, Y, and Z, refer to Materials and Methods) was
made. The lacZ gene was expressed in the first and second
branchial arches, otic vesicle, frontonasal mesenchyme,
and the notochord in the 9.5-dpc embryo (Fig. 3, c–e; Ta-
ble I d). At 13.5 dpc, lacZ activity was detected in the cranio-
facial chondrogenic tissues (e.g., the frontonasal, occipital,
parietal, and facial mesenchyme), the axial (prevertebrae
and ribs) and appendicular skeleton (Fig. 4, a–e, limb carti-
lages). Expression of the pKL9 transgene at both ages was
very similar to that of cosHcol2 (Fig. 2, a, c and e) and
Col2a1 (Figs. 2 b, d, f and 3 b; Table I c). These observa-
tions suggest that the regulatory elements of pKL9 are suf-
ficient for driving the COL2A1-specific expression in
transgenic mice. Some necessary regulatory elements may,
however, be missing in pKL9 since at 9.5 dpc lacZ trans-
gene expression was absent from the dorsal half of the otic
vesicle and the brain (Fig. 3, c–e). A construct (pKL8) con-
taining only the 6.1-kbp 59 flanking region but without the
intron 1 sequence linked to the reporter gene did not ex-
press in all the transgenic embryos (Table I d). Some criti-
cal tissue-specific regulatory elements are therefore present
within the first intron of the gene.
DNA Modules for COL2A1 Expression during
Early Organogenesis
In the mouse, Col2a1 is expressed early at 8.0–8.5 dpc. A
distinct craniocaudal gradient of Col2a1 mRNA expres-
sion was observed in the paraxial mesoderm (Fig. 3 a). In
addition, the midline notochord displayed a uniform ex-
pression throughout its length (Fig. 3 a). A 309-bp frag-
ment (region Y) of the first intron of the COL2A1 gene
(84.1% homologous to the minimal enhancer of the rat
type II collagen gene [Krebsbach et al., 1996]) when linked
Figure 1. Schematic representation of constructs used to gener-
ate transgenic mice in this study. Each construct contains a lacZ
cassette flanked on the 59 side by upstream sequences from the
following genes: COL2A1 (hatched box); human b-globin gene
promoter (cross-striped box); mouse Col10a1 59 flanking DNA
(stippled box) and on the 39 side by COL2A1 first intron se-
quences (black or white boxes) or the SV-40 enhancer (vertically
striped box). Numbers indicate the positions of the nucleotide in
the sequence relative to the start site of transcription in the
COL2A1 gene. For ease of reference, the intron 1 sequences ana-
lyzed have been subdivided into three regions, designated X, Y,
and Z (refer to Materials and Methods). ATG, translation start
site; pA, polyadenylation signal.The Journal of Cell Biology, Volume 141, 1998 1294
in normal orientation to the lacZ gene and 6.1-kbp 59
flanking  COL2A1 sequence (pKL80.3), could direct trans-
gene expression like that of endogenous Col2a1 in early
organogenesis stage mouse embryos. b-galactosidase ac-
tivity was found in the paraxial mesoderm and was ex-
pressed strongly in the node and notochord at 8.5 dpc (Fig.
3, f–i; Table I d). At 9.5 dpc, pKL80.3 transgene was ex-
pressed in the first and second branchial arch and the
paraxial mesoderm (Fig. 3, j and k), like that of the endog-
enous Col2a1 (Fig. 3 b). pKL80.3 expression was stronger
in the newly formed somites than in the more mature
somites (Fig. 3 j). These findings indicate that region Y, to-
gether with 6.1-kbp 59 flanking DNA, was sufficient to
drive lacZ expression in tissues that normally express
mouse  Col2a1 during early organogenesis (Table I d).
Identification of Minimal 59 Flanking Sequence for 
COL2A1 Expression
The 6.1-kbp 59 flanking sequence was systematically exam-
ined in conjunction with 2.1 kbp of the intron 1 sequence
(regions X, Y, and Z) to determine the minimal upstream
DNA required to regulate appropriate lacZ expression.
The 59 flanking sequence was reduced to 1.5 kbp (21
to 21,500) (pKL10, and pKL10 which differs by the orien-
tation of the intron 1 sequence, refer to Fig. 1) and also to
90 bp (21 to 290, pKL12, refer to Fig. 1). None of these
constructs showed any significantly different expression
patterns from one another (Fig. 3, l–n; Table I d) or that of
pKL9 (Fig. 3, c–e). Constructs pKL9 and pKL80.3 were
expressed in chondrogenic tissues (Fig. 4, a–d and e–j; Ta-
ble I d) and were appropriately downregulated in the hy-
pertrophic chondrocytes like the endogenous Col2a1 (Fig.
4, i and j; Ng et al., 1993; Lui et al., 1995). pKL10, pKL10R,
and pKL12 transgenes were expressed in the same pre-
chondrogenic and chondrogenic tissue types as pKL9 and
pKL80.3 (Table I d). Reduction of the 59 flanking se-
quence of pKL9 to 1500 (21 to 21,500, pKL10 and
pKL10R) or 90 bp (21 to 290, pKL12) did not seem to af-
fect the expression of the transgene (Fig. 4, k–m at 13.5
dpc). Transgene expression was found in the notochord
when the transgene was regulated by 6.1-kbp, 1.5-kbp, or
90-bp upstream sequence in combination with 2.1-kbp first
intron (Fig. 3, c and e, pKL9; Fig. 3 l, pKL10; Fig. 3 m,
pKL10R; Fig. 3 n, pKL12). Similar notochord expression
was also achieved with region Y and 6.1-kbp 59 flanking
DNA (Fig. 3, f–k, pKL80.3). Therefore, the 59 flanking se-
quence 21 to 290 with 2.1-kbp intron 1 sequence is suffi-
cient for COL2A1 expression, and 6.1 kbp is required if
only region Y of intron 1 is present. 
Separate Regulatory Elements Direct Expression in 
Different Components of the Cartilaginous Skeleton
The pKL10 construct was modified by deleting region
Y1Z from the intron 1 fragment (refer to Fig. 1,
pKL10X). This transgene was expressed in sites that nor-
mally would express Col2a1 (Fig. 5, a–e; e.g., craniofacial
mesenchyme, paraxial mesoderm, and prevertebrae), ex-
cept the notochord, the second branchial arch (Fig. 5, a
and b, 9.5 dpc), and the digits of the limbs (Fig. 5, c and f,
14.5 dpc). Transgene expression was generally patchy (Fig.
5 a) and reduced in limbs, digits, the upper trunk, vertebral
cartilage, and rib cage (Fig. 5 c). A similar expression pat-
tern was observed (Fig. 5, g–l) for construct pKL12X con-
taining the minimal 90-bp (21 to 290) 59 flanking se-
quence and region X (refer to Fig. 1). Together, these
results suggest that at least two separable modules of
DNA are present in intron 1. Region X may contain regu-
latory elements for the first branchial arch, facial skeleton,
and lower trunk vertebrae. Indeed, deletion of region X
from pKL10R (Fig. 1, pKL10RX) led to loss of expression
in most tissues except the limbs and digits (Fig. 5, m–q; Ta-
ble I d). Region Y1Z may contain regulatory elements for
Figure 2. A comparison of the expression of the human COL2A1
(a and c, 9.5-dpc; e and g, 14.5-dpc embryo) and mouse Col2a1 (b
and d, 9.5-dpc; f and h, 14.5-dpc embryo) genes in transgenic (a–f)
and nontransgenic (g and h) embryos. The transgenic embryos
are heterozygous for a transgenic locus containing a 9.1-kbp 59
and a 1.7-kbp 39 flanking sequences and the COL2A1 gene
(cosHcol2 construct). In the transgenic embryos, transcripts of
the cosHcol2 transgene are found in the first branchial arch (as-
terisk), frontonasal (fn) and cranial paraxial mesenchyme (cm)
(a), the otic vesicle (ov) and prechondrogenic trunk mesenchyme
(tm) (c), the prevertebrae (pv) and the chondrocranial cartilage
(cc) (e). These tissues in the transgenic mice also express the en-
dogenous mouse Col2a1 (b, d, and f). The cosHcol2 transgene is
not expressed in the heart tissues (he) that express the endoge-
nous Col2a1 gene (compare c with d). In the nontransgenic em-
bryo, no COL2A1 mRNA is detected in the chondrogenic mes-
enchyme (g) and expression of the endogenous Col2a1 transcript
is shown in (h). Bar, 200 mm.Leung et al. Regulation of COL2A1 Expression 1295
regulating  COL2A1 expression in the second branchial
arch, notochord, upper trunk (axial), and limb (appendicu-
lar) cartilage.
Positive and Negative Regulatory Elements for 
Expression in the Ventral Midbrain
The lacZ reporter was expressed in the neuroepithelium
of the ventral midbrain for constructs containing 1.5-kbp
(21 to 21,500) 59 fragment and regions X1Y1Z (Fig. 3, l
and m; Table I d, pKL10 and pKL10R). In contrast, mid-
brain expression was absent for constructs containing ad-
ditional sequences from 21,500 to 26,100 (Fig. 3, c and d,
pKL9) or only 90-bp 59 fragment (Fig. 3 n, 21 to 290
pKL12). This suggests that negative elements that sup-
press midbrain expression may be localized in the se-
quence between 21,500 and 26,100, and positive elements
may be found between 290 and 21,500.
Although pKL12 was not expressed in the midbrain of
the transgenic embryo, the removal of region Y1Z from
pKL12 (i.e., pKL12X) has resulted in the reexpression of
the lacZ reporter in the midbrain (Fig. 5, g and h; Table I
d). Exchanging region X for Y1Z (pKL10RX) resulted in
loss of midbrain expression (Table I d). These findings
therefore suggest that negative regulatory elements con-
trolling midbrain expression may be localized in region
Y1Z. These elements may act in an orientation-indepen-
dent manner, since midbrain expression was similar for
pKL10 and pKL10R (refer to Fig. 3, l and m). Deletion of
the same region (Y1Z) from pKL10 (i.e., pKL10X),
which was expressed in the midbrain, has no effect on the
expression of the reporter (compare Fig. 3 l with Fig. 5, a
and b). Therefore, it suggests that the positive elements
found between 290 and 21,500 could overcome the nega-
tive effect of region Y1Z.
Tissue-specific Expression Requires Both COL2A1 59 
and Intron 1 Sequences
To investigate whether region Y needs to interact specifi-
cally with the COL2A1 promoter, we replaced the 6.1-kbp
59 flanking sequence of pKL80.3 with heterologous pro-
moter fragments from the human b-globin and mouse type
X collagen (Col10a1) genes (refer to Fig. 1, pKL21 and
pWP16 constructs). The human b-globin promoter frag-
ment has been shown to cooperate with tissue-specific ele-
ments from heterologous genes, such as myogenin (Yee
and Rigby, 1993) and Hoxa2 (Nonchev et al., 1996), to
Table I. Expression Pattern of COL2A1 in Human, cosHcol2 Transgene in Mouse, Col2a1 in Mouse, and COL2A1-lacZ in 
Transgenic Mice
Gene Age/dpc Tg lacZ Ch (Ap) Sm/Ch (Ax) Ba1 Ba2 Ov* Fn/Sn Br No
a COL2A1 in 27–29 — — N 11 1 1 ‡ 111
human fetuses 42–44 — — 11 NN 1 ‡ 222
b cosHcol2 in 9.5 1 — N 11 1 1 1 1 1
mouse 14.5 1 — 11 NN 11 1 1
c mouse  Col2a1 8.5 — — N 1 NN N N11
9.5 — — N 11 1 1 1 1 1
13.5 — — 11 NN 11 1 1
d COL2A1-lacZ
pKL9 9.5 19 5 N 1 4 2 4 3 — 4
13.5 10 4 4 4 N N 4 4 1§ 4
pKL8 9.5 4 — N — — — — — — —
12.5 16 — — — N N — — — —
pKL80.3 8.5 2 2 N 2 N N N N — 2
9.5 21 7 N 4 6 3 6 1 1§ 7
14.5 13 10 10 10 N N 5 — 2§ 7
pKL10 9.5 12 4 N 1 2 3 2 1 3§ 3
13.5 22 7 7 7 N N 7 7 — 7
pKL10R 8.5 4 3 N — N N N N — 3
9.5 6 4 N 2 4 4 4 3 3§ 4
13.5 3 3 3 3 N N 3 3 — 3
pKL12 9.5 20 5 N — 5 3 3 1 — 2
14.5 1 1 1 1 N N 1 1 — 1
15.5 4 3 3 3 N N 1 1 — 1
pKL10X 9.5 18 6 N 4 4 — 5 3 3§ 1
14.5 5 4 — 4 N N 4 4 — 4
pKL12X 9.5 8 5 N 5 5 1 5 5 5§ 1
13.5 11 8 — 6 N N 8 7 6§ —
pKL10RX 9.5 11 9 N 2 1 1 — 2 — —
14.5 15 9 9 — N N — 2 — —
Tg, number of transgenic embryos detected by PCR for lacZ sequence; lacZ, number of transgenic embryos expressing the lacZ transgene; dpc, days post coitum; Ch, chondro-
cytes; Sm, somites; Ap, appendicular skeleton; Ax, axial skeleton; Ba, branchial arch; Ov, otic vesicle; Fn, frontonasal mesenchyme; Sn, snout; Br, brain; He, heart; No, notochord;
Nd, node; N, tissues not present.
*Ventral portion.
‡Full expression.
§Expressed in midbrain only.
For the expression of COL2A1 gene from Lui et al., (1995): 1, expressed; 2, not expressed.The Journal of Cell Biology, Volume 141, 1998 1296
Figure 3. The delineation of minimal COL2A1 sequences required for expression of the lacZ reporter in prechondrogenic tissues.
Col2a1 is expressed in the heart (he), notochord (no), and somites (sm) of (a) 8.5- and (b) 9.5-dpc embryos. The tissue-specific pattern of
Col2a1 expression is emulated by that of the COL2A1-lacZ transgene with a 6.1-kbp 59 flanking and regions X, Y, and Z of intron 1 in
the pKL9 transgenic embryo (c–e). The transgene is expressed in the frontonasal mesenchyme (fn), otic vesicle (ov), first (asterisk) and
second (s) branchial arches (c and d) and notochord (no) (c and e). Reduction of the first intron to region Y in pKL80.3 embryos still al-
lows the full expression of the reporter gene in prechondrogenic tissues both in 8.5- (f–i) and 9.5-dpc (j and k) embryos and mimics the
expression of Col2a1 gene (a, 8.5 dpc; b, 9.5 dpc). Transgene expression is found in the node (nd) and notochord (no) of the three-
somite stage embryo but not in the embryonic heart (f and g). In the eight-somite stage pKL80.3 embryo, transgene expression is found
in the notochord (no), neural crest cells (nc) (h and i), and somites (sm) (h). At 9.5 dpc, pKL80.3 is expressed in a pattern (j and k) sim-
ilar to that of the endogenous Col2a1 (b). In addition, it is found to express in the paraxial mesenchyme (pm) (j). Reduction of the 59 se-
quence of pKL9 to 1.5 kbp (l, pKL10; m, pKL10R) and 90 bp (n, pKL12) allows the full expression of the reporter gene, suggesting thatLeung et al. Regulation of COL2A1 Expression 1297
drive tissue-specific lacZ expression in 9.5-dpc transgenic
mice embryos. The Col10a1 promoter fragment can direct
lacZ expression in developing bone of 14.5-dpc transgenic
mouse fetuses (Poon, W.S., and K.S.E. Cheah, unpub-
lished data).
The b-globin promoter (pKL21) was unable to direct
transgene expression in the Col2a1 pattern despite the
presence of region Y of intron 1 (seven expressing em-
bryos showing low and nonspecific expression, data not
shown). Furthermore, type X collagen promoter was also
the 21 to290 fragment of the COL2A1 gene acts like a minimal promoter in conjunction with regions X, Y, and Z of intron 1. The in-
tron 1 sequence functions as an enhancer element and gives the same reporter gene expression when placed in either orientation (com-
pare l with m). It is interesting to find transgene expression in the midbrain (mb) of pKL10 and pKL10R (l and m). Bars: (a–c, h, j, and
l–n) 500 mm; (d and e) 200 mm; (g, i, and k) 100 mm.
Figure 4. Delineation of the minimal COL2A1 sequences needed to direct expression of the transgene in chondrogenic tissues. pKL9
embryo at 13.5 dpc (a) shows characteristic chondrogenic expression in the snout (sn), digits (dg), limb (lc), ribs (rb), prevertebrae (pv),
facial skeleton (fs) and parietal (pa), and occipital (oc) mesenchyme. Histological sections of pKL9 13.5-dpc embryos show reporter
gene expression in the condensation of the nasal mesenchyme (sn) (b), prevertebrae (pv), notochord (no) (c), and mesenchymal con-
densation of the zygopods (lc), and digits (dg) of the limb (d). Deletion of the intron 1 to region Y in pKL80.3 does not affect expression
of the transgene in chondrogenic tissues (e–j), indicating that region Y of intron 1, in conjunction with 6.1-kbp 59 flanking sequence, con-
tains sufficient cis-acting tissue-specific elements to direct chondrogenic expression. Histological sections of pKL80.3 14.5-dpc embryos
show similar lacZ expression in chondrogenic tissues (f–h) as in pKL9 embryos (b–d). Transgene expression in the hypertrophic chon-
drocytes (hc) (j) is weaker than that in young chondrocytes (yc) (i), which mimics the endogenous Col2a1 expression pattern. Reduction
of the 59 flanking sequences to 1.5 kbp in pKL10 (k) and pKL10R (l) and 90 bp in pKL12 (m) also has no effect, indicating that only 90-bp
59 flanking sequence is enough to give chondrogenic expression in conjunction with regions X, Y, and Z of intron 1. Bars: (a, e, and k–m)
500 mm; (b–d and f–h) 200 mm; (i and j) 50 mm.
Figure 5. Demonstration of
separable regulatory mod-
ules in the first intron. Dele-
tion of regions Y and Z from
pKL10 and pKL12 causes re-
stricted and patchy expres-
sion of the reporter in the
paraxial mesoderm (pm),
the first branchial arch mes-
enchyme (asterisk), and the
mesenchyme in the midbrain
(mb) and frontonasal (fn) re-
gions of the 9.5-dpc pKL10X
(a and b) and pKL12X (g and
h) embryos. lacZ expression
is found in the snout (sn), fa-
cial skeleton (fs), and the
prevertebrae (pv) but not in
the cartilage of the digits (dg)
of the 14.5-dpc pKL10X
transgenic fetus (c–f) and
that of the 15.5-dpc pKL12X
transgenic fetus (i–l). Dele-
tion of region X from
pKL10R (refer to Fig. 1,
pKL10RX) leads to the loss
of expression in most tissues
except the digits and limbs
(lc) (m–o). No expression in
the snout (sn) (p) or ribs (rb)
(q) is found. Bars: (a, c, g, i,
and m) 500 mm; (b, d–f, h, j–l,
and n–q) 200 mm.The Journal of Cell Biology, Volume 141, 1998 1298
unable to substitute for the COL2A1 59 flanking sequence
and no expression was seen in seven transgenic embryos.
The specific requirement for intron 1 sequence is further
demonstrated by the inappropriate expression of pKL28
construct, in which the intron 1 fragment was replaced by
the SV-40 enhancer (refer to Fig. 1). Only one of six trans-
genic embryos expressed lacZ and was not in a pattern
characteristic of the Col2a1 (pKL9/pKL80.3) pattern (data
not shown).
Discussion
Different Combinations of DNA Modules Confer 
Specific Expression of the COL2A1 Gene
In this study, we have identified DNA elements that regu-
late the expression of the COL2A1 gene by assaying the
expression of COL2A1-lacZ transgenes in mouse em-
bryos. We found that the 6.1-kbp upstream region and the
first intron of COL2A1 contain regulatory elements re-
quired for transcription in tissues that normally express
the endogenous mouse type II collagen gene. The first in-
tron operates in an orientation-independent manner.
These results agree with other studies using cell transfec-
tion assays and transgenic mice, which demonstrate an en-
hancer role of the first intron of type II collagen genes
(Horton et al., 1987; Wang et al., 1991; Seghatoleslami et
al., 1994; Metsäranta et al., 1995; Mukhopadhyay et al.,
1995; Zhou et al., 1995; Krebsbach et al., 1996; Lefebvre
et al., 1996).
In our experiments, neither the first intron nor the
COL2A1 5 9  flanking DNA could be substituted by en-
hancer or promoters of unrelated genes. These results are
consistent with the report that the promoter and first in-
tron of the rat type II collagen gene act synergistically
(Savagner et al., 1995), but contrast with another report
showing that mouse Col2a1 intron 1 sequences linked to
the human b-globin or adenovirus major late promoters
could direct transcription in chondrocytes (Mukhopadhyay
et al., 1995; Zhou et al., 1995). These contradictory find-
ings could be related to differences on the strength of the
promoter–enhancer interaction and the proximity of the
promoter to sequences in the first intron, which may affect
the efficiency of transcription. In the constructs tested in
the present study, the first intron sequences are separated
from the promoter sequence by at least 3 kbp of lacZ
DNA. This may hamper the formation of the correct pro-
moter-enhancer loop, and thus diminishes the activity of
the heterologous promoters. Furthermore, in other stud-
ies, multiple intron 1 sequences are placed immediately
upstream of heterologous promoters. This arrangement
may facilitate the stabilization of promoter–intron interac-
tions allowing the expression of the transgene (Mukho-
padhyay et al., 1995; Zhou et al., 1995).
The requirement for proper physical configuration and/
or differing combination of integrity of regulatory ele-
ments for transgene expression has also been shown in the
present study. Appropriate expression of the lacZ trans-
gene is achieved by a combination of either the 6.1-kbp 59
flanking fragment and region Y, or a 90-bp 59 flanking se-
quence and the 2.1-kbp intron 1 sequence containing
X1Y1Z. Therefore, regions X and Z may contain some
elements that interact with the short (90-bp) 59 flanking
sequence. The deletion of sequences 21,500 to 26,100 re-
sulted in the loss of lacZ expression. Both combinations of
regulatory elements were equally effective for correct tis-
sue-specific expression, despite sequence differences be-
tween modules. The results are consistent with the notion
that sufficient lengths of specific combinations of the 59
flanking sequence and intron 1 of COL2A1 are essential
to achieve the appropriate conformation for establishing
the necessary heteromeric complex to activate transcrip-
tion.
COL2A1 Activity in the Midbrain Is Regulated by 
Positive and Negative Regulatory Elements
Transgene expression in the midbrain is found to be mod-
ulated by a combination of positive and negative elements.
DNA sequences in the upstream region 21,500 to 26,100
and region Y1Z of intron 1 seem to exert a suppressive
activity, whereas the sequences in the 21 to 21,500 region
and region X are required for the expression of the
COL2A1 transgene (Fig. 6). The data also suggest that ex-
pression of COL2A1 in different skeletal elements may be
mediated by different combinations of regulatory ele-
ments. For example, 1.5-kbp with region Z1Y gave limb
expression only (Fig. 5 m) but 1.5-kbp region X gave ex-
pression in the axial skeleton but not in the limbs (Fig. 5
Figure 6. A summary of the organization of promoter and en-
hancer elements of the human COL2A1 gene as revealed by in
vivo reporter activity in transgenic mouse embryos. The 1.6-kbp
intron 1 (1701 to 12,387) sequence (region X) contains the en-
hancer elements that are required, in conjunction with a minimal
90-bp fragment of the 59 flanking region of the COL2A1 gene, to
direct prechondrogenic and chondrogenic and some nonchondro-
genic expression of the reporter. Expression of the reporter is
found in the midbrain, first branchial arch, craniofacial mesen-
chyme, and axial skeleton. Region Y of intron 1 (12,388 to
12,696) in conjunction with 6.1-kbp 59 flanking sequence confers
similar prechondrogenic and chondrogenic enhancer activity.
With this combination of regulatory elements, the transgene is
expressed widely in the chondrogenic tissues (axial and appendic-
ular skeleton and craniofacial mesenchyme), branchial arch 1 and
2, notochord, and node. Midbrain-positive elements may be
present in the sequences from 290 to 21,500 and from 1701 to
12,387 (region X). On the other hand, midbrain-negative ele-
ments may be present in the sequences from 21,500 to 26,100
and 12,388 to 12,855 (region Y1Z). Our study also shows that
chondrogenic expression of the reporter can be achieved only by
using homologous 59 flanking and intron 1 sequences of the
COL2A1 gene and substituting either one with heterologous reg-
ulatory elements results in nonspecific reporter expression.Leung et al. Regulation of COL2A1 Expression 1299
c). Recently, cis-acting elements that control a2(XI) col-
lagen gene expression in different cartilaginous compo-
nents of the skeleton (Tsumaki and Kimura, 1995) and
separable DNA modules for tissue and site-specific ex-
pression of the a1(I) (Sokolov et al., 1995; Rossert et al.,
1995, 1996) and a1(VI) collagen genes (Braghetta et al.,
1996) have been described. The differential impact of se-
lective enhancer and repressor elements of the COL2A1
gene on lacZ reporter activity in the brain suggests lin-
eage-specific or region-specific deployment of regulatory
elements may be a common mechanism of gene regulation.
Some Regulatory Motifs Identified by Cell Transfection 
Assays Have No Function In Vivo
Region Y contains the analogous sequences to those in the
rodent type II collagen genes shown to be important for
enhancer activity in transfected chondrocytes (Wang et al.,
1991; Krebsbach et al., 1996; Lefebvre et al., 1996) but not
all the motifs identified were present in this region. An
AT-rich element previously shown to be important for the
enhancer activity and for transcriptional regulation of the
Col2a1 gene (Krebsbach et al., 1996) was absent in region
Y, suggesting that this sequence is not essential for tissue-
specific expression of COL2A1 in vivo.
The 90-bp upstream region of COL2A1 is highly con-
served among human, mouse, and rat and contains many
potential transcription factor–binding motifs, including a
potential Sp1-binding site (275 to 280) (Vikkula et al.,
1992). In the rat Col2a1 gene, a potential Sp1-binding site
outside this 90-bp region (2114 to 2119) interacts with
the first intron enhancer via a complex consisting of Sp1
factor and a zinc finger protein, CIIZFP (Savagner et al.,
1995). Our results showing appropriate transgene expres-
sion in the absence of this Sp1-binding site (construct
pKL12) suggest either that the site is redundant or the
other potential Sp1-binding site (274 to 280) or yet unde-
fined elements within the 90-bp sequence are sufficient for
gene expression. The increased specific binding activity to
Sp1 motifs found for nuclear extract prepared from non-
Col2a1–expressing cells such as fibroblasts and dedifferen-
tiated chondrocytes suggest that the Sp1-binding site may
mediate negative regulation of the gene (Dharmavaram
et al., 1997).
The rat type II collagen gene contains two sequence ele-
ments at positions 2421 to 2436 and 2657 to 2666 which
behave as silencers in cell transfection assays (Savagner
et al., 1990). This region is not well conserved between hu-
man and rat type II collagen gene (Vikkula et al., 1992)
and the silencing activity has not been tested in vivo.
Omitting the 290 to 21,500 region of COL2A1 did not
change the tissue-specificity of transgene expression, sug-
gesting that the putative silencer elements in the 59 flank-
ing DNA do not play any role in the regulation of
COL2A1 activity in transgenic mice.
Molecular Mechanisms for Regulation of COL2A1 
Expression: A Model of the Organization of COL2A1 
Lineage-specific Regulatory Elements
The main structural and functional features of the DNA
modules regulating lineage-specific expression of human
COL2A1 (Fig. 6) are: (a) early organogenesis and chon-
drogenic expression are regulated by the interaction of el-
ements in the upstream (21 to 26,100) region and the
309-bp region Y of the first intron and of elements in 21
to 290 region and region X of the first intron; (b) expres-
sion in the midbrain tissue is mediated by interactions be-
tween positive elements in the 21 to 21,500 region and
the negative elements in 21,500 to 26,100 and region
Y1Z of the first intron; (c) critical regulatory elements for
gene expression in the notochord are found in the region
21 to 21,500 and region Y of the first intron.
Such an interplay of positive and negative regulation to
achieve defined expression patterns has been found for
many developmentally regulated genes (Ip and Hema-
vathy, 1997). Transcription factors such as Bicoid, Dorsal,
snail, and Elf-1 regulate patterning in the Drosophila em-
bryo by restricting gene expression to specific sites (Nov-
ina and Roy, 1996; Ip and Hemavathy, 1997). We and oth-
ers have recently shown that SOX9 directly regulates the
mouse and human type II collagen genes via SRY/SOX
binding motifs found in the Y region of the first intron
(Bell et al., 1997; Lefebvre et al., 1997). However, the ex-
pression of SOX9 does not always transactivate the Col2a1
gene, especially in nonchondrogenic tissues, suggesting that
other factors are also required (Bell et al., 1997). Future
challenges lie in identifying those additional factors which
bind to and interact with the various activating/repressing
DNA modules in vivo, to direct appropriate tissue-specific
expression of COL2A1 during key differentiation events
in organogenesis and chondrogenesis.
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